Eastern Bank’s AstraZeneca AZN Stock Holding History

Eastern Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$176K	Sell	1,092 -5,000	-82%	-$833K	﹤0.01%	407
2026 Q2	$1.14M	Buy	+6,092	New	+$1.15M	0.02%	196
2026 Q1	–	Sell	-558	Closed	-$103K	–	1086
2025 Q4	$103K	Sell	558 -246	-31%	-$43.1K	﹤0.01%	455
2025 Q3	$123K	Hold	804	–	–	﹤0.01%	430
2025 Q2	$112K	Sell	804 -64	-7%	-$8.97K	﹤0.01%	437
2025 Q1	$128K	Buy	868 +538	+163%	+$77.8K	﹤0.01%	410
2024 Q4	$43.2K	Sell	330 -66	-17%	-$9.24K	﹤0.01%	585
2024 Q3	$61.7K	Buy	+396	New	+$63.9K	﹤0.01%	530
2021 Q1	–	Sell	-4,250	Closed	-$425K	–	185
2020 Q4	$425K	Hold	4,250	–	–	0.02%	145
2020 Q3	$466K	Sell	4,250 -1,600	-27%	-$178K	0.03%	136
2020 Q2	$619K	Hold	5,850	–	–	0.04%	127
2020 Q1	$523K	Hold	5,850	–	–	0.04%	132
2019 Q4	$583K	Hold	5,850	–	–	0.03%	124
2019 Q3	$521K	Sell	5,850 -938	-14%	-$81.3K	0.03%	132
2019 Q2	$560K	Buy	6,788 +938	+16%	+$73.5K	0.04%	131
2019 Q1	$473K	Hold	5,850	–	–	0.03%	142
2018 Q4	$444K	Hold	5,850	–	–	0.03%	142
2018 Q3	$463K	Hold	5,850	–	–	0.03%	149
2018 Q2	$411K	Hold	5,850	–	–	0.03%	156
2018 Q1	$409K	Hold	5,850	–	–	0.03%	160
2017 Q4	$406K	Hold	5,850	–	–	0.03%	154
2017 Q3	$396K	Hold	5,850	–	–	0.03%	156
2017 Q2	$399K	Hold	5,850	–	–	0.03%	160
2017 Q1	$364K	Sell	5,850 -100	-2%	-$5.82K	0.03%	161
2016 Q4	$325K	Hold	5,950	–	–	0.03%	161
2016 Q3	$391K	Hold	5,950	–	–	0.03%	151
2016 Q2	$359K	Buy	5,950 +100	+2%	+$5.81K	0.03%	157
2016 Q1	$329K	Hold	5,850	–	–	0.03%	161
2015 Q4	$397K	Hold	5,850	–	–	0.03%	149
2015 Q3	$372K	Hold	5,850	–	–	0.03%	155
2015 Q2	$373K	Sell	5,850 -208	-3%	-$14.2K	0.03%	150
2015 Q1	$415K	Hold	6,058	–	–	0.03%	145
2014 Q4	$426K	Hold	6,058	–	–	0.03%	148
2014 Q3	$433K	Sell	6,058 -220	-4%	-$16.1K	0.04%	142
2014 Q2	$467K	Sell	6,278 -415	-6%	-$30K	0.04%	136
2014 Q1	$434K	Buy	+6,693	New	+$432K	0.04%	142

Other funds holding AZN

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

PNC

Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return

CCM

Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CNBT

Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Eastern Bank's AZN Position: Q3 2026 in Review

Eastern Bank reduced its AstraZeneca (AZN) stake by 82% in Q3 2026, selling an estimated $833K and leaving 1,092 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Eastern Bank first reported a position in AZN in Q1 2014 and has held it in 36 quarters since. The position peaked at $1.14M in Q2 2026. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Eastern Bank held 1,092 shares of AstraZeneca worth $176K as of Q3 2026.
Eastern Bank sold 5,000 AstraZeneca shares in Q3 2026, an estimated $833K.
AstraZeneca made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #407 holding.
Eastern Bank first reported a position in AstraZeneca in Q1 2014 and has held it in 36 quarters since.
Eastern Bank's AstraZeneca position peaked at $1.14M in Q2 2026.
47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.